Loading...
Expansion and differentiation of ex vivo cultured erythroblasts in scalable stirred bioreactors
Date
2022
Abstract
Transfusion of donor‐derived red blood cells (RBCs) is the most common form of cell therapy. Production of transfusion‐ready cultured RBCs (cRBCs) is a promising replacement for the current, fully donor‐dependent therapy. A single transfusion unit, however, contains 2 × 1012 RBC, which requires large scale production. Here, we report on the scale‐up of cRBC production from static cultures of erythroblasts to 3 L stirred tank bioreactors, and identify the effect of operating conditions on the efficiency of the process. Oxygen requirement of proliferating erythroblasts (0.55–2.01 pg/cell/h) required sparging of air to maintain the dissolved oxygen concentration at the tested setpoint (2.88 mg O2/L). Erythroblasts could be cultured at dissolved oxygen concentrations as low as 0.7 O2 mg/ml without negative impact on proliferation, viability or differentiation dynamics. Stirring speeds of up to 600 rpm supported erythroblast proliferation, while 1800 rpm led to a transient halt in growth and accelerated differentiation followed by a recovery after 5 days of culture. Erythroblasts differentiated in bioreactors, with final enucleation levels and hemoglobin content similar to parallel cultures under static conditions.
Supervisor
Description
Publisher
Wiley and Sons Ltd
Citation
Biotechnology and Bioengineering,2022, 119,pp. 3096– 3116
Collections
Files
Funding code
Funding Information
ZonMW TAS program, Grant/Award Number:116003004; Landsteiner Foundation for Bloodtransfusion Research, Grant/Award Number: 1239; Sanquin Blood Supply, Grant/Award Numbers: PPOC17‐28, PPOC19‐14; European Union, Marie Skłodowska‐Curie Innovative Training Networks, Grant/Award Number: 860436 (EVIDENCE)